TISTR joins hands with TCELS, National Laboratory Animal Center, TOPT Network, to enhance drug security cope with the epidemic Participate in enhancing research abilities according to good practice Advanced Medical Product Safety Testing, Drugs, Vaccines
Mr. Sayan Tanpanich, Deputy Governor of Research and Development, Bio-Industry Group Thailand Institute of Science and Technology Research (TISTR), Ministry of Higher Education, Science, Research and Innovation (TSU) presided over the opening ceremony of the training course. “Advanced Medical Product Safety Testing Practices (ATMPs), Drugs, Vaccines, Medical Devices, New Chemicals according to the OECD GLP Principles”, which TISTR works with partners including the Center of Excellence for Life Sciences or TCELS. National and TOPT network organized to strengthen drug security support the epidemic and the state of war in Thailand by developing the competence of personnel in the country to be ready to test the safety of health products Under the international standard product safety information acceptance system Build Confidence Equivalent to International on April 27, 2022 at Arnoma Grand Hotel, Bangkok
Deputy Governor of Research and Development of Bio-Industry Group, TISTR said that TISTR and TCELS have given importance to research and assessment of the safety of drugs, vaccines, and medical devices related to COVID-19. It is important to develop human resources and good laboratory standards in the country to keep up with the global situation. In order to upgrade the ability of personnel to have knowledge An understanding of the principles of international standards In this cooperation, TCELS, National Laboratory Animal Center and TOPT Network will jointly build and develop personnel with expertise in both cellular and animal testing fields. For work in toxicology in the safety assessment Pharmacology in efficacy and efficacy testing to support the development of drugs, vaccines, medical devices New chemicals from around the world This will drive developments to enhance the product safety assessment infrastructure. Develop personnel and continue to respond to government policy driving